Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A children's cancer group study

John M. Maris, Matthew J. Weiss, Chun Guo, Robert B. Gerbing, Daniel O. Stram, Peter S. White, Michael D. Hogarty, Erik P. Sulman, Patricia M. Thompson, John N. Lukens, Katherine K. Matthay, Robert C. Seeger, Garrett M. Brodeur

Research output: Contribution to journalArticlepeer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A children's cancer group study'. Together they form a unique fingerprint.

Medicine & Life Sciences